“Pretreatment of the cells with PKC inhibitors, CGP 41251 or tamoxifen , inhibited tyrosine phosphorylation of Erk1 and Erk2 MAP kinases induced by low concentrations of SP or TPA and significantly attenuated phosphorylation at high concentrations of SP or TPA.”